The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Pediatric Clinical Trials Market Grow Between 2026 And 2030?
The pediatric clinical trials market size has experienced robust growth in recent years. It is anticipated to expand from $18.38 billion in 2025 to $19.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historic period stems from limited pediatric-specific drug research, reliance on adult trial data, ethical and regulatory challenges, low patient recruitment rates, and minimal use of advanced analytics in trial design.
The pediatric clinical trials market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $26.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. The projected growth during the forecast period stems from factors such as an escalating demand for therapies tailored to children, the wider uptake of digital and AI tools, an increase in regulatory incentives for pediatric research, enhanced collaboration between pharmaceutical companies and research institutions, and a greater emphasis on patient-centric and personalized clinical trials. Key trends expected in the forecast period encompass the expanding integration of precision medicine into pediatric clinical trials, a greater utilization of AI and digital technologies for designing trials and analyzing data, the increasing incorporation of real-world evidence into pediatric research, a surge in investment dedicated to pediatric drug development, and a heightened focus on therapeutics that are personalized and age-specific.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp
What Primary Drivers Are Shaping The Pediatric Clinical Trials Market?
An increase in pediatric cancer cases is anticipated to propel the pediatric clinical trials market going forward. Pediatric cancer refers to malignancies that develop in children and adolescents under the age of 14. These cancers are notably uncommon, and their patterns of growth and dissemination can differ significantly from those seen in adult tumors. Pediatric clinical trials continue to play a crucial role in advancing both prognosis and treatment. For instance, in January 2023, the American Cancer Society, a US-based voluntary health organization, estimated that approximately 9,910 children in the US under the age of 15 would be diagnosed with cancer, and about 1,040 children under the age of 15 are expected to die from cancer in 2023. Thus, the escalating healthcare expenditure is driving the pediatric clinical trials market.
Which Segment Classifications Are Used In The Pediatric Clinical Trials Market Segment Analysis?
The pediatric clinical trials market covered in this report is segmented –
1) By Phase: Phase I, Phase II, Phase III, Phase IV
2) By Study Design: Treatment Studies, Observational Studies
3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas
Subsegments:
1) By Phase I: First-in-Pediatrics Trials, Dose Escalation Studies, Safety And Tolerability Assessments
2) By Phase II: Efficacy Studies, Dose Optimization Trials, Pharmacokinetic Studies
3) By Phase III: Large-Scale Efficacy Trials, Comparative Studies, Long-Term Safety Studies
4) By Phase IV: Post-Marketing Surveillance, Long-Term Safety Monitoring, Effectiveness Studies In Real-World Settings
What Trends Are Affecting The Growth Of The Pediatric Clinical Trials Market?
Organizations engaged in pediatric clinical trials are prioritizing collaboration and partnerships to ensure the provision of reliable services to their customers. A strategic partnership represents a structured affiliation between two or more commercial enterprises, typically established through formal business agreements or contracts. For instance, in September 2023, Strados Labs, a US-based provider of smart biosensors for respiratory monitoring, partnered with Ann & Robert H. Lurie Children’s Hospital, a US-based pediatric acute care children’s hospital, to conduct a clinical trial for the RESP Biosensor. This RESP Biosensor is a wearable device that utilizes acoustic sensors to monitor lung sounds for asthma symptoms like coughing and wheezing. The aim of this clinical trial is to assess the effectiveness of the RESP Biosensor in accurately detecting and tracking asthma exacerbations in children.
Which Firms Are Contributing To The Pediatric Clinical Trials Market Ecosystem?
Major companies operating in the pediatric clinical trials market are Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp – Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences
Get The Full Pediatric Clinical Trials Market Report:
https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report
Which Region Is The Top Contributor To The Pediatric Clinical Trials Market By Share?
North America was the largest region in the pediatric clinical trials market in 2025. The regions covered in the pediatric clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Pediatric Clinical Trials Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report
Browse Through More Reports Similar to the Global Pediatric Clinical Trials Market 2026, By The Business Research Company
Brain Tumor Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report
Pediatric Imaging Market Report
https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report
Paraganglioma Market Report
https://www.thebusinessresearchcompany.com/report/paraganglioma-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model